Athanassios Dovas

Columbia University Irving Medical Center — United States

Medicine · Health Sciences

25h-index3.1kcitations76works4.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(18), Cellular Mechanics and Interactions(18), Ferroptosis and cancer prognosis(13), Immune cells in cancer(10), Microtubule and mitosis dynamics(8)

Publications76 total

IDH-mutant inhibitors enhance the sensitivity of IDH1-mutant gliomas to cysteine-methionine deprivation and ferroptosis
2026Open Access
TMET-43. IDH1(R132H) inhibitors enhance the sensitivity of IDH1-mutant glioma to cysteine deprivation and ferroptosis
Neuro-Oncology·2025· 1 citedOpen Access
CNSC-75. PROMINENT GLIOMA CALCIUM TRANSIENTS CAN BE REPEATEDLY TRIGGERED BY STIMULUS-EVOKED NEURONAL ACTIVITY AND PURINERGIC SIGNALING
Neuro-Oncology·2025
CNSC-60. STIMULUS-EVOKED INCREASES IN INTRACELLULAR CALCIUM PROMOTE SUSCEPTIBILITY TO FERROPTOSIS IN GLIOMA CELLS
Neuro-Oncology·2025Open Access
CNSC-57. HUMAN AND MOUSE PERITUMORAL SLICES DEMONSTRATE MTOR-DEPENDENT GABAERGIC NEURONAL DYSFUNCTION IN GLIOMA
Neuro-Oncology·2025Open Access
EXTH-18. MT-125 Inhibits Non-Muscle Myosin IIA and IIB and Prolongs Survival in Glioblastoma
Neuro-Oncology·2025Open Access
MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastoma
Cell·2025· 13 citedOpen Access
Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition
Neuron·2025· 14 cited
A selective small-molecule agonist of G protein-gated inwardly-rectifying potassium channels reduces epileptiform activity in mouse models of tumor-associated and provoked seizures
Neuropharmacology·2024· 2 citedOpen Access
Resistance to spindle inhibitors in glioblastoma depends on STAT3 and therapy induced senescence
iScience·2024· 1 citedOpen Access
TMIC-78. CHEMOTHERAPY INDUCED IMMUNOGENIC RESPONSE IN GLIOMA AND IMPLICATIONS FOR THERAPEUTIC STRATEGIES
Neuro-Oncology·2024Open Access
CSIG-03. MT-125 INHIBITS NON-MUSCLE MYOSIN IIA AND IIB, SYNERGIZES WITH ONCOGENIC KINASE INHIBITORS, AND PROLONGS SURVIVAL IN GLIOBLASTOMA
Neuro-Oncology·2024Open Access
A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma
The EMBO Journal·2024· 14 citedOpen Access
Resistance to Spindle Inhibitors in Glioblastoma Depends on STAT3 and Therapy Induced Senescence
2024Open Access
MT-125 Inhibits Non-Muscle Myosin IIA and IIB, Synergizes with Oncogenic Kinase Inhibitors, and Prolongs Survival in Glioblastoma
2024· 2 citedOpen Access
Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons
Cell stem cell·2024· 23 citedOpen Access
Glioma-Induced Alterations in Excitatory Neurons are Reversed by mTOR Inhibition
2024· 5 citedOpen Access
DDDR-15. RESISTANCE TO TARGETED ANTI-MITOTICS IN GLIOBLASTOMA IS DRIVEN BY STAT3 ACTIVATION AND THERAPY INDUCED SENESCENCE
Neuro-Oncology·2023· 1 citedOpen Access
EXTH-20. A MOUSE MODEL REVEALS VULNERABILITY OF IDH1-MUTATED GLIOMA TO FERROPTOSIS
Neuro-Oncology·2023· 1 citedOpen Access
TMIC-24. FERROPTOSIS INDUCES IMMUNOGENIC CELL DEATH AND SYNERGIZES WITH CD47 BLOCKADE TO REPROGRAM THE GLIOMA MICROENVIRONMENT
Neuro-Oncology·2023· 2 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Peter Canoll(32), Jeffrey N. Bruce(21), Peter A. Sims(17), Nelson Humala(15), Pavan S. Upadhyayula(14), Matei A. Banu(13), Aayushi Mahajan(12), Dianne Cox(12), Brian Gill(10), Michael Argenziano(10), Guy M. McKhann(9), Angeliki Mela(9), Tejaswi Sudhakar(9), Dominique Higgins(8), Brent R. Stockwell(8), Wenting Zhao(8), Alexander Goldberg(8), Catherine A. Schevon(8), Steven S. Rosenfeld(8), John S. Condeelis(7)